Cerebrospinal fluid and plasma leptin measurements: Covariability with dopamine and cortisol in fasting humans

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 10, 1999, Pages 3579-3585

  Hagan, Mary M ^a   Havel, Peter J ^c   Seeley, Randy J ^a   Woods, Stephen C ^a   Ekhator, Nosa N ^a   Baker, Dewleen G ^a,b   Hill, Kelly K ^a,b   Wortman, Matthew D ^a,b   Miller, Andrew H ^d   Gingerich, Ronald L ^e   Geracioti Jr , Thomas D ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Linco Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LIPOTROPIN; CYTOKINE; DOPAMINE; GLUCOCORTICOID; HYDROCORTISONE; LEPTIN; MONOAMINE; THYROID HORMONE;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; ENERGY METABOLISM; HUMAN; MALE; OBESITY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SMOKING; URINE LEVEL;

EID: 0033305706     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.10.3579     Document Type: Article

References (59)

1. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance
2. Weight-reducing effects of the plasma protein encoded by the obese gene
3. Expression of OB mRNA and its encoded protein in rodents
4. High fat meals reduce 24 hour circulating leptin concentrations in women
5. Diurnal and ultradian rhythmicity of plasma leptin: Effects of gender and adiposity
6. Short term response of circulating leptin to feeding and fasting in man: Influence of circadian cycle
7. Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women
8. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels
9. Relationship between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women
10. Effects of the obese gene product on body weight regulation in ob/ob mice
11. Recombinant Ob protein reduces feeding and body weight in the ob/ob mouse
12. Positional cloning of the mouse obese gene and its human homologue
13. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
14. Congenital leptin deficiency is associated with severe early-onset obesity in humans
15. Mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks
16. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice
17. The effect of intraventricular administration of leptin on food intake and body weight in the rat
18. Food intake in diabetic rats: Isolation of primary metabolic effects of fat feeding
19. Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques
20. Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting
21. Localization of leptin mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization
22. Identification of hypothalmic targets of leptin action
23. Relation of leptin and neuropeptide Y in human blood and cerebrospinal fluid
24. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans
25. Human blood-brain barrier leptin receptor: Binding and endocytosis in isolated human brain microvessels
26. Identification and expression cloning of a leptin receptor, OB-R
27. Cerebrospinal fluid and plasma B-endorphin in combat veterans with post-traumatic stress disorder
28. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans
29. Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid
30. Radioimmunoassay of leptin in human plasma
31. Low cerebrospinal fluid dopamine metabolite concentrations in tobacco smokers
32. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes
33. Sex differences in circulating human leptin pulse amplitude: Clinical implications
34. Circulating leptin has saturable transport into intrathecal space in humans
35. Cerebrospinal fluid leptin in anorexia nervosa: Correlation with nutritional status and potential role in resistance to weight gain
36. Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy men
37. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity
38. Pulsatile secretion of ACTH and cortisol in premenopausal women: Effect of obesity and body fat distribution
39. Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans
40. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: Leptin inhibits cortisol release directly
41. The hypothalamic response to starvation: Implications for the study of wasting disorders
42. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin
43. Central leptin stimulates corticosterone secretion at the onset of the dark cycle
44. Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants
45. What's in a name? In search of leptin's physiologic role
46. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress
47. Low cerebrospinal fluid conticotropin-releasing hormone concentrations in eucortisolemic depression
48. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats
49. Effects of chronic administration of the amphetamines and other stimulants on behavior
50. Bromocriptine reduces obesity, glucose intolerance and extracellular monoamine metablite levels in the ventromedial hypothalamus of Syrian hamsters
51. Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice
52. Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice
53. Bromocriptine/SKF38393 ameliorates islet dysfunction in the diabetic (db/db) mouse
54. Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women
55. Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics
56. Plasma leptin and insulin relationships in obese and nonobese humans
57. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: Reversal by insulin administration
58. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus